Award
Delivery Order #SPE2DR26FCHZ4
Short-term Delivery Order for Xtandi Tablets by DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8,844.32
Ceiling
$8,844.32
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FCHZ4
NAICS
424210
This award represents a delivery order contract under a long-term indefinite delivery vehicle previously established with DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical supply to government healthcare sectors. The award covers the provision of Xtandi 40 mg tablets, a critical pharmaceutical product, to support specialized medical treatments. The contract underscores the agency's commitment to ensuring continuous access to essential medications, enhancing public health capabilities. The scope involves the timely delivery of specified pharmaceuticals within a short timeframe, ensuring immediate replenishment needs are met. This contract was awarded as a task order under the existing IDV agreement, streamlining procurement and maintaining supply chain efficiency. The period of performance is brief, highlighting the flexibility and responsiveness of the delivery mechanism within the broader long-term supply contract.
Description
4571064051!XTANDI 40 MG TABLET 120S